Course Directors: Dr Jeremy Rees and Dr Jonathan Martin
The National Hospital for Neurology and Neurosurgery, University College London Hospitals Foundation Trust & UCL Institute of Neurology
The need for multidisciplinary working in neuro-oncology is well established but a common theme that will be addressed is the need for better understanding between core specialties within the Neuro-oncology Multidisciplinary Team.
To address this, this course has been designed for Trainees, Consultants and Clinical Nurse Specialists in the core specialities of neuro-oncology – Neurology, Neurosurgery, Clinical Oncology, Neuroradiology, Neuropathology and Palliative Care.
The Aims of the Course are:
- To introduce the basic principles and recent advances in Neuro-oncological treatments
- To develop a standardised approach to the diagnosis and classification of brain and spinal tumours using modern imaging, histopathology and molecular genetic techniques.
- To develop an understanding of the multidisciplinary management of patients with primary and metastatic brain and spine tumours, and other rarer tumours of the nervous system.
- To develop an understanding of the symptomatic management of the brain tumour patient with neurological symptoms, including palliative and end-of-life care and treatment related toxicity.
- To provide an opportunity for multidisciplinary discussion of common and rare cases
The course will be divided into four days throughout 2017-2018 and will be delivered by the consultant staff of the UCLH/UCL/National Hospital Neuro-oncology multidisciplinary team. There will be a series of lectures followed by an opportunity to discuss Case Presentations at the end of the day.
Feedback from the first course held on the 30th November 2017
“Presenters all excellent and easy to listen to. Thank you”
“Great range of medical disciplines to give teaching of breadth and depth of neuro-oncology”
“Very interesting lectures to a high standard”
“Very good study day. Learned a lot”
“Well received by all and long awaited”
Dates and programmes:
- 30th November 2017 Basic Principles – Epidemiology, Pathology, Imaging, Surgery, Radiotherapy, Chemotherapy, Biological Agents, Symptomatic treatments, End of Life care
- 25th January 2018 Gliomas/Teenage Young Adult Tumours (medulloblastoma, germ cell tumours)
- 12th April 2018 Benign and Metastatic Tumours – Skull Base, Pituitary, Spinal tumours, Cord compression
- 11th July 2018 Leptomeningeal Metastases, Neurotoxicity, Paraneoplastic Syndromes, Rare Tumours (Primary CNS lymphoma, pineal tumours), Ethical Considerations
|Category||Early Bird Day rate||Day rate||Early Bird Full course rate||Full course rate|
|Trainees (non UK)||120||135||400||450|
|Allied professionals (physios, nurses etc)||100||120||340||400|
CPD points will be available.
Special offer: Discounted Membership to the British Neuro-oncology Society for 2017/18 of £ 25 (normally £75) with a further £100 discount off conference registration for BNOS 2018 if you book the whole course rate by November 2017.
Booking on the course
Click on the links below to book individual days or the whole course.
30th November 2017 Basic Principles – Epidemiology, Pathology, Imaging, Surgery, Radiotherapy, Chemotherapy, Biological Agents, Symptomatic treatments, End of Life care
25th January 2018 Gliomas/Teenage Young Adult Tumours (medulloblastoma, germ cell tumours)
12th April 2018 Benign and Metastatic Tumours – Skull Base, Pituitary, Spinal tumours, Cord compression